Literature DB >> 12147647

Angiogenesis, thrombospondin, and ductal carcinoma in situ of the breast.

A Rice1, C M Quinn.   

Abstract

Angiogenesis, the growth of new vessels from existing vasculature, plays an essential role in tumour development. The process involves interaction between a variety of cells, growth factors, and components of the extracellular matrix, regulated by pro-angiogenic and anti-angiogenic factors. This review profiles these factors, outlines the available methods for measuring new vessel formation, and discusses the importance of angiogenesis in breast cancer, with emphasis on ductal carcinoma in situ.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12147647      PMCID： PMC1769713          DOI： 10.1136/jcp.55.8.569

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


  97 in total

1.  Angiostatin: a circulating endothelial cell inhibitor that suppresses angiogenesis and tumor growth.

Authors:  M S O'Reilly; L Holmgren; Y Shing; C Chen; R A Rosenthal; Y Cao; M Moses; W S Lane; E H Sage; J Folkman
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1994

2.  Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer.

Authors:  L F Brown; B Berse; R W Jackman; K Tognazzi; A J Guidi; H F Dvorak; D R Senger; J L Connolly; S J Schnitt
Journal:  Hum Pathol       Date:  1995-01       Impact factor: 3.466

Review 3.  The modulation of thrombospondin and other naturally occurring inhibitors of angiogenesis during tumor progression.

Authors:  O V Volpert; V Stellmach; N Bouck
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

4.  Novel methods for the determination of the angiogenic activity of human tumors.

Authors:  M Barbareschi; G Gasparini; L Morelli; S Forti; P Dalla Palma
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

Review 5.  Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors.

Authors:  N Weidner
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

6.  Biologic and clinical significance of basic fibroblast growth factor immunostaining in breast carcinoma.

Authors:  D W Visscher; F DeMattia; S Ottosen; F H Sarkar; J D Crissman
Journal:  Mod Pathol       Date:  1995-08       Impact factor: 7.842

7.  Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin.

Authors:  P C Brooks; S Strömblad; R Klemke; D Visscher; F H Sarkar; D A Cheresh
Journal:  J Clin Invest       Date:  1995-10       Impact factor: 14.808

8.  Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in cervical neoplasia.

Authors:  A J Guidi; G Abu-Jawdeh; B Berse; R W Jackman; K Tognazzi; H F Dvorak; L F Brown
Journal:  J Natl Cancer Inst       Date:  1995-08-16       Impact factor: 13.506

9.  Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis.

Authors:  D L Weinstat-Saslow; V S Zabrenetzky; K VanHoutte; W A Frazier; D D Roberts; P S Steeg
Journal:  Cancer Res       Date:  1994-12-15       Impact factor: 12.701

10.  Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels.

Authors:  P C Brooks; A M Montgomery; M Rosenfeld; R A Reisfeld; T Hu; G Klier; D A Cheresh
Journal:  Cell       Date:  1994-12-30       Impact factor: 41.582
View more
  26 in total

1.  Thrombospondin 1 protein expression relates to good prognostic indices in ductal carcinoma in situ of the breast.

Authors:  A J Rice; M A Steward; C M Quinn
Journal:  J Clin Pathol       Date:  2002-12       Impact factor: 3.411

2.  [Functional and molecular imaging of breast tumors].

Authors:  K Pinker; P Brader; G Karanikas; K El-Rabadi; W Bogner; S Gruber; M Reisegger; S Trattnig; T H Helbich
Journal:  Radiologe       Date:  2010-11       Impact factor: 0.635

3.  DCEMRI of breast lesions: is kinetic analysis equally effective for both mass and nonmass-like enhancement?

Authors:  Sanaz A Jansen; Xiaobing Fan; Gregory S Karczmar; Hiroyuki Abe; Robert A Schmidt; Maryellen Giger; Gillian M Newstead
Journal:  Med Phys       Date:  2008-07       Impact factor: 4.071

Review 4.  Is DCIS breast cancer, and how do I treat it?

Authors:  N Bijker; M Donker; J Wesseling; G J den Heeten; E J Th Rutgers
Journal:  Curr Treat Options Oncol       Date:  2013-03

5.  PDGF-D improves drug delivery and efficacy via vascular normalization, but promotes lymphatic metastasis by activating CXCR4 in breast cancer.

Authors:  Jieqiong Liu; Shan Liao; Yuhui Huang; Rekha Samuel; Tony Shi; Kamila Naxerova; Peigen Huang; Walid Kamoun; Rakesh K Jain; Dai Fukumura; Lei Xu
Journal:  Clin Cancer Res       Date:  2011-04-01       Impact factor: 12.531

6.  Angiogenesis in the progression of breast ductal proliferations.

Authors:  Philip M Carpenter; Wen-Pin Chen; Aaron Mendez; Christine E McLaren; Min-Ying Su
Journal:  Int J Surg Pathol       Date:  2009-04-29       Impact factor: 1.271

7.  Lack of lymphangiogenesis during breast carcinogenesis.

Authors:  M M Vleugel; R Bos; P van der Groep; A E Greijer; A Shvarts; H V Stel; E van der Wall; P J van Diest
Journal:  J Clin Pathol       Date:  2004-07       Impact factor: 3.411

8.  Diffuse optical tomography of the breast: preliminary findings of a new prototype and comparison with magnetic resonance imaging.

Authors:  Stephanie M W Y van de Ven; Sjoerd G Elias; Andrea J Wiethoff; Marjolein van der Voort; Tim Nielsen; Bernhard Brendel; Claas Bontus; Falk Uhlemann; Rami Nachabe; Rik Harbers; Michiel van Beek; Leon Bakker; Martin B van der Mark; Peter Luijten; Willem P Th M Mali
Journal:  Eur Radiol       Date:  2009-01-10       Impact factor: 5.315

9.  Magnetic resonance imaging of the natural history of in situ mammary neoplasia in transgenic mice: a pilot study.

Authors:  Sanaz A Jansen; Suzanne D Conzen; Xiaobing Fan; Erica J Markiewicz; Gillian M Newstead; Gregory S Karczmar
Journal:  Breast Cancer Res       Date:  2009       Impact factor: 6.466

10.  A novel fluorescent imaging agent for diffuse optical tomography of the breast: first clinical experience in patients.

Authors:  Stephanie van de Ven; Andrea Wiethoff; Tim Nielsen; Bernhard Brendel; Marjolein van der Voort; Rami Nachabe; Martin Van der Mark; Michiel Van Beek; Leon Bakker; Lueder Fels; Sjoerd Elias; Peter Luijten; Willem Mali
Journal:  Mol Imaging Biol       Date:  2009-10-02       Impact factor: 3.488
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.